RESTON, Va.--The Journal of Nuclear Medicine and Journal of Nuclear Medicine Technology are now publishing articles online in advance of print publication to bring new research to readers at the earliest possible date, according to SNM, an international scientific and professional organization dedicated to advancing molecular imaging and therapy. The June issues of both SNM publications can now be viewed online.
"SNM believes it is vital to publish and disseminate important new scientific and clinical information at the earliest possible date to those in the molecular imaging and therapy and nuclear medicine community," said SNM President Martin P. Sandler, who speaks for more than 16,000 molecular imaging/nuclear medicine physician, technologist and scientist members. "JNM--the profession's most important and influential international journal--will now deliver significant, scholarly, peer-reviewed research faster; this is increasingly important as we see rapid advancements in molecular imaging and technology," he added.
"Time matters, and expedited, online, ahead-of-print publishing is important to bring to scientists and clinicians valuable information about molecular and nuclear imaging and therapy," noted Heinrich R. Schelbert, editor in chief of SNM's flagship journal. "Researchers need to quickly communicate their discoveries so that others may benefit from their results and cite publications," he added. SNM members and journal subscribers will be able to read the latest research one or two months in advance of print publication, said Schelbert. "JNM's acceptance-to-publication turnaround is already quite short, and publishing ahead of print shortens it even further," he added.
All published-ahead-of-print articles are considered officially published and are searchable. Each article may be cited using its unique digital object identifier (DOI), which the article will retain when published; all articles will remain on the JNM Web site for reference.
Published since 1960, JNM covers monthly a broad spectrum of subjects from basic science and chemistry investigations to clinical studies, molecular biology, therapies and advanced technologies, along with continuing medical education articles, invited perspectives and commentaries, procedure guidelines, book reviews and professional news. JNM's articles are consistently ranked among the world's most-cited medical imaging research, and it is in the top 5 percent of other publications in its category and the more than 6,000 publications rated by the Thomson Institute for Scientific Information's Journal Citation Report.
JNMT, which has been published since 1973, is a quarterly peer-reviewed publication that focuses on technology, quality assurance, radiation safety, expert perspectives and clinical applications of nuclear medicine and molecular imaging.
JNM and JNMT ahead-of-print articles will be available on the journals' Web sites (http://jnm.snmjournals.org; http://tech.
About SNM--Advancing Molecular Imaging and Therapy
SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (the Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.